NCT07423923
Representation of Spatiotemporal Information in Human Episodic Memory and Navigation
Enrolling by Invitation
EARLY_PHASE1Ages 18–40InterventionalBasic scienceUniversity of ArizonaInvestigator-initiated
~15 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:Scopolamine
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
behavioral: navigational accuracy
Measured over from enrollment to end of study (3 days)
+3 more outcomes measured
Conditions
Where it's being run
2 sites across 2 statesArizona1
Texas1
Study leadership
- Arne Ekstrom, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Arizona McKnight Brain Institute
- Brad Lega, M.D. · STUDY_DIRECTOR · University of Texas, Southwestern Medican Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- behavioral: navigational accuracyfrom enrollment to end of study (3 days)
accuracy (path error) of routes taken in virtual environment
- intracranial EEG low-frequency oscillatory powerfrom enrollment to the end of study (3 days)
approximate amplitude of signal recorded from the hippocampus of patients undergoing seizure monitoring
- memory accuracy (as part of memory training component involving healthy controls)from enrollment to the end of study (3 weeks)
how many words remembered
- Route replay timefrom enrollment to the end of study (3 days)
time (in seconds) it takes to remember a route that will or has been taken